> top > docs > PubMed:9794238 > annotations

PubMed:9794238 JSONTXT

Annnotations TAB JSON ListView MergeView

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 21-33 protein denotes IkappaBalpha
T2 59-67 protein denotes TNFalpha
T3 96-129 cell_type denotes EBV-infected lymphoblastoid cells
T4 166-175 protein denotes NF-kappaB
T5 237-249 protein denotes IkappaBalpha
T6 255-275 cell_type denotes lymphoblastoid cells
T7 323-332 protein denotes NF-kappaB
T8 412-424 protein denotes IkappaBalpha
T9 551-560 protein denotes cytokines
T10 587-591 protein denotes BrdU
T11 691-706 cell_type denotes apoptotic cells
T12 884-892 protein denotes TNFalpha
T13 925-943 cell_line denotes transfected clones
T14 965-995 cell_line denotes IkappaBalpha transfected cells
T15 1024-1032 protein denotes TNFalpha
T16 1120-1128 protein denotes TNFalpha
T17 1168-1185 cell_line denotes transfected cells
T18 1265-1278 DNA denotes TNFalpha gene
T19 1310-1319 protein denotes NF-kappaB
T20 1351-1388 cell_type denotes NF-kappaB protects EBV-infected cells
T21 1415-1423 protein denotes TNFalpha
T22 1475-1483 protein denotes cytokine

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-130 Sentence denotes Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells.
S2 131-276 Sentence denotes In order to understand the role of NF-kappaB in EBV transformation we have established stably transfected IkappaBalpha into lymphoblastoid cells.
S3 277-425 Sentence denotes Two clones were obtained in which the loss of NF-kappaB binding activity correlated with the constitutive expression of the transgenic IkappaBalpha.
S4 426-491 Sentence denotes Protein latency expression was determined by immunocytochemistry.
S5 492-676 Sentence denotes Expression of surface markers, intracytoplasmic content of cytokines cell cycle analysis after BrdU incorporation and DNA staining with propidium iodide were studied by flow cytometry.
S6 677-764 Sentence denotes Percentage of apoptotic cells was determined by in-situ labelling of DNA strand breaks.
S7 765-853 Sentence denotes No significative changes in EBV latency nor in cell surface marker expression was found.
S8 854-944 Sentence denotes In contrast, intracytoplasmic TNFalpha levels were strongly reduced in transfected clones.
S9 945-1043 Sentence denotes Furthermore, 30% of IkappaBalpha transfected cells were apoptotic after 8 h of TNFalpha treatment.
S10 1044-1139 Sentence denotes This correlated with a strong reduction of BrdU incorporation after 24 h of TNFalpha treatment.
S11 1140-1235 Sentence denotes No effect was seen with non transfected cells or with cells transfected with a control plasmid.
S12 1236-1484 Sentence denotes Our results suggest that the TNFalpha gene could be one of the targets of NF-kappaB in EBV infected cells and that NF-kappaB protects EBV-infected cells from apoptosis induced by TNFalpha, which may favour the proliferative effect of this cytokine.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 166-175 NP denotes NF-kappaB
C2 277-287 NP denotes Two clones
C3 305-310 NP denotes which
C4 587-605 NP denotes BrdU incorporation
C5 1024-1042 NP denotes TNFalpha treatment
C6 1087-1105 NP denotes BrdU incorporation
C7 1120-1138 NP denotes TNFalpha treatment
C8 1310-1319 NP denotes NF-kappaB
C9 1323-1341 NP denotes EBV infected cells
C10 1351-1360 NP denotes NF-kappaB
C11 1370-1388 NP denotes EBV-infected cells
C12 1415-1423 NP denotes TNFalpha
C13 1470-1483 NP denotes this cytokine
R1 C3 C2 coref-relat which,Two clones
R2 C6 C4 coref-ident BrdU incorporation,BrdU incorporation
R3 C7 C5 coref-ident TNFalpha treatment,TNFalpha treatment
R4 C8 C1 coref-ident NF-kappaB,NF-kappaB
R5 C10 C8 coref-ident NF-kappaB,NF-kappaB
R6 C11 C9 coref-ident EBV-infected cells,EBV infected cells
R7 C13 C12 coref-ident this cytokine,TNFalpha

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 21-33 protein_molecule denotes IkappaBalpha
T2 59-67 protein_molecule denotes TNFalpha
T3 96-129 cell_type denotes EBV-infected lymphoblastoid cells
T4 166-175 protein_complex denotes NF-kappaB
T5 237-249 protein_molecule denotes IkappaBalpha
T6 255-275 cell_type denotes lymphoblastoid cells
T7 323-332 protein_complex denotes NF-kappaB
T8 370-393 other_name denotes constitutive expression
T9 412-424 protein_molecule denotes IkappaBalpha
T10 426-452 other_name denotes Protein latency expression
T11 471-490 other_name denotes immunocytochemistry
T12 523-547 other_name denotes intracytoplasmic content
T13 551-560 protein_family_or_group denotes cytokines
T14 587-591 protein_molecule denotes BrdU
T15 628-644 other_organic_compound denotes propidium iodide
T16 661-675 other_name denotes flow cytometry
T17 691-706 cell_type denotes apoptotic cells
T18 725-742 other_name denotes in-situ labelling
T19 793-796 virus denotes EBV
T20 812-842 other_name denotes cell surface marker expression
T21 867-883 other_name denotes intracytoplasmic
T22 884-892 protein_molecule denotes TNFalpha
T23 925-943 cell_line denotes transfected clones
T24 965-977 protein_molecule denotes IkappaBalpha
T25 1024-1032 protein_molecule denotes TNFalpha
T26 1087-1091 nucleotide denotes BrdU
T27 1120-1128 protein_molecule denotes TNFalpha
T28 1168-1185 cell_line denotes transfected cells
T29 1265-1273 protein_molecule denotes TNFalpha
T30 1310-1319 protein_complex denotes NF-kappaB
T31 1323-1326 virus denotes EBV
T32 1351-1360 protein_complex denotes NF-kappaB
T33 1370-1373 virus denotes EBV
T34 1415-1423 protein_molecule denotes TNFalpha
T35 1446-1466 other_name denotes proliferative effect
T36 1475-1483 protein_family_or_group denotes cytokine